At SyntheX, we are harnessing evolution in our synthetic biology based selection platforms, ToRPPIDO and ToRNeDO, to create and identify molecules that disrupt or bridge previously 'undruggable' protein-protein interactions for therapeutic and biotechnological applications.
We identify relevant drug targets based on clinical, evolutionary, and phenotypic features.
Using our evolutionary cell-based platform, we select targeted compounds that modulate protein-protein interactions.